Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland
…, S Hutchinson, TM Caparrotta… - The lancet Diabetes & …, 2021 - thelancet.com
Background We aimed to ascertain the cumulative risk of fatal or critical care unit-treated
COVID-19 in people with diabetes and compare it with that of people without diabetes, and to …
COVID-19 in people with diabetes and compare it with that of people without diabetes, and to …
Relation of incident type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland
…, LE Bath, DA McAllister, TM Caparrotta… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE Studies using claims databases reported that severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection >30 days earlier was associated with an increase in …
coronavirus 2 (SARS-CoV-2) infection >30 days earlier was associated with an increase in …
Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature
TM Caparrotta, DJ Antoine, JW Dear - European journal of clinical …, 2018 - Springer
Purpose Paracetamol is one of the world’s most commonly used drugs. In overdose, it is well
established to be hepatotoxic. The aim of this review was to identify factors that have been, …
established to be hepatotoxic. The aim of this review was to identify factors that have been, …
Safety and efficacy of the SNAP 12-hour acetylcysteine regimen for the treatment of paracetamol overdose
JM Pettie, TM Caparrotta, RW Hunter… - …, 2019 - thelancet.com
Background Acetylcysteine (NAC) is effective at preventing liver injury after paracetamol
overdose. The Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol Poisoning (…
overdose. The Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol Poisoning (…
Rapid epidemiological analysis of comorbidities and treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): a population-based case-control study
…, R Wood, N Lone, J Murray, TM Caparrotta… - PLoS …, 2020 - journals.plos.org
Background The objectives of this study were to identify risk factors for severe coronavirus
disease 2019 (COVID-19) and to lay the basis for risk stratification based on demographic …
disease 2019 (COVID-19) and to lay the basis for risk stratification based on demographic …
Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study
…, R Wood, N Lone, J Murray, TM Caparrotta… - BMC medicine, 2021 - Springer
Background The objective of this study was to investigate the relation of severe COVID-19 to
prior drug prescribing. Methods Severe cases were defined by entry to critical care or fatal …
prior drug prescribing. Methods Severe cases were defined by entry to critical care or fatal …
Sodium–glucose co-transporter 2 inhibitors (SGLT2i) exposure and outcomes in type 2 diabetes: a systematic review of population-based observational studies
TM Caparrotta, AM Greenhalgh, K Osinski, RM Gifford… - Diabetes Therapy, 2021 - Springer
Introduction Sodium–glucose co-transporter 2 inhibitors (SGLT2is) are licensed for the
treatment of type 2 diabetes (T2D) and more recently for heart failure with or without diabetes. …
treatment of type 2 diabetes (T2D) and more recently for heart failure with or without diabetes. …
The management of ventricular dysrhythmia in aconite poisoning
JM Coulson, TM Caparrotta, JP Thompson - Clinical Toxicology, 2017 - Taylor & Francis
Introduction: Aconite poisoning is relatively rare but is frequently complicated by ventricular
dysrhythmias, which may be fatal. Molecular basis of aconite alkaloid ventricular …
dysrhythmias, which may be fatal. Molecular basis of aconite alkaloid ventricular …
Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide …
…, FW Gibb, JA McKnight, JE O'Reilly, TM Caparrotta… - Diabetologia, 2022 - Springer
Aims/hypothesis We assessed the real-world effect of flash monitor (FM) usage on HbA 1c
levels and diabetic ketoacidosis (DKA) and severe hospitalised hypoglycaemia (SHH) rates …
levels and diabetic ketoacidosis (DKA) and severe hospitalised hypoglycaemia (SHH) rates …
Development and validation of a cardiovascular risk prediction model in type 1 diabetes
…, M Colombo, S Livingstone, B Farran, TM Caparrotta… - Diabetologia, 2021 - Springer
Aims/hypothesis We aimed to report current rates of CVD in type 1 diabetes and to develop
a CVD risk prediction tool for type 1 diabetes. Methods A cohort of 27,527 people with type 1 …
a CVD risk prediction tool for type 1 diabetes. Methods A cohort of 27,527 people with type 1 …
